Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Interleukin-2 signaling pathway	33/847	2.015810891784652E-5	0.011550596409926055	0	0	2.3783783783783785	25.714798519185113	EPHB6;RERE;MACF1;KMT2C;TCF7;RASGRP2;ADD3;SAMHD1;MLLT3;SMC4;DPP4;INPP5F;TCOF1;STK38;S1PR1;FAM53B;KCNN4;GTF2I;DENND2D;TIA1;VPS13A;ARHGEF18;IL16;MAPK11;GPRC5B;SBK1;SELL;RASA1;ID3;EVL;IL6ST;BRWD1;SSBP2
PIP2 hydrolysis	4/25	9.095681546878825E-4	0.2605912763180783	0	0	10.680272108843537	74.78903934295316	DGKA;PRKCQ;RASGRP2;DGKZ
ATM-mediated phosphorylation of repair proteins	2/5	0.0030156138904512977	0.5189896968060926	0	0	37.202651515151516	215.92239836302443	MDC1;ATM
Mitochondrial tRNA aminoacylation	3/21	0.005771826924680999	0.5189896968060926	0	0	9.320037986704653	48.04262074687076	RARS2;MARS2;TARS2
Cation-coupled chloride cotransporters	2/7	0.006185805016440239	0.5189896968060926	0	0	22.319318181818183	113.50485077276629	SLC12A6;SLC12A7
Double-strand break repair	3/22	0.006596574676786956	0.5189896968060926	0	0	8.82905982905983	44.33251717851837	MDC1;PRKDC;ATM
Mismatch repair	3/23	0.007487858339882865	0.5189896968060926	0	0	8.387179487179488	41.05081900257275	MSH2;MSH3;MLH3
Lysine degradation	4/44	0.007501839475537371	0.5189896968060926	0	0	5.601714285714285	27.406986666928187	SETDB1;NSD1;EHMT1;ASH1L
Recruitment of repair and signaling proteins to double-strand breaks	2/8	0.00815167063046219	0.5189896968060926	0	0	18.598484848484848	89.45001523541566	MDC1;ATM
IGF1 receptor signaling through beta-arrestin	3/25	0.009474692765196985	0.5428998954457872	0	0	7.6239316239316235	35.52089582310672	MAPK11;INSR;IGF1R
Arrhythmogenic right ventricular cardiomyopathy (ARVC)	5/75	0.010609696395992909	0.5526687304458124	0	0	4.0065493246009005	18.21372091074413	CACNB1;LEF1;TCF7;ITGA6;CACNA2D4
Phosphatidylinositol signaling system	5/78	0.012436072467404389	0.5938224603185596	0	0	3.8413078462927346	16.852408927809112	INPP4B;PIKFYVE;DGKA;DGKZ;PLCB2
Thromboxane A2 receptor signaling	4/56	0.0172164816966479	0.7298351075243686	0	0	4.3063736263736265	17.492007855172982	MAPK11;TBXA2R;PRKCQ;PLCB2
PIP biosynthesis at the early endosome membrane	2/13	0.021421711913835267	0.7298351075243686	0	0	10.142045454545455	38.97943339850745	INPP4B;PIKFYVE
Ion channel transport	4/61	0.022849009463301463	0.7298351075243686	0	0	3.927619047619048	14.841873466606488	GABRR2;ATP8A1;ATP11C;ATP1B3
Colorectal cancer	4/62	0.024094599733075588	0.7298351075243686	0	0	3.859704433497537	14.380361496411954	MSH2;MSH3;LEF1;TCF7
Interleukin-6 regulation of target genes	2/14	0.02470346748364804	0.7298351075243686	0	0	9.296401515151516	34.404231134913964	ABCC4;ABCC5
Ion transport by P-type ATPases	3/36	0.02551259663594163	0.7298351075243686	0	0	5.07977207977208	18.635565308106823	ATP8A1;ATP11C;ATP1B3
Rap1 signaling	2/16	0.031829852877781964	0.7298351075243686	0	0	7.967532467532467	27.466878309110555	RASGRP2;PRKACB
Dilated cardiomyopathy	5/100	0.03251337286014516	0.7298351075243686	0	0	2.9484240687679084	10.10160691090638	CACNB1;PRKAG2;ITGA6;CACNA2D4;PRKACB
PAC1 receptor pathway	3/40	0.033535860390247745	0.7298351075243686	0	0	4.529683529683529	15.378909527315132	PRKCQ;PRKACB;PLCB2
Energy-dependent regulation of mTOR by LKB1-AMPK	2/17	0.03565925324012097	0.7298351075243686	0	0	7.435984848484848	24.78968926483515	CAB39L;PRKAG2
Plasma membrane estrogen receptor signaling	3/41	0.035722959678904556	0.7298351075243686	0	0	4.410256410256411	14.694805307911121	MAPK11;PLCB2;IGF1R
Activated AMPK stimulation of fatty-acid oxidation in muscle	2/18	0.03965632130974999	0.7298351075243686	0	0	6.970880681818182	22.49855166852595	CAB39L;PRKAG2
Adherens junction cell adhesion	4/74	0.04224032597590766	0.7298351075243686	0	0	3.1960816326530614	10.113616548658822	INSR;LEF1;TCF7;IGF1R
Small ligand GPCRs	2/19	0.043813958216413304	0.7298351075243686	0	0	6.560494652406417	20.519933750674706	TBXA2R;S1PR1
Class C GPCRs (metabotropic glutamate and pheromone receptors)	2/19	0.043813958216413304	0.7298351075243686	0	0	6.560494652406417	20.519933750674706	GPRC5B;GRM6
Transfer RNA aminoacylation	3/46	0.04772365005249184	0.7298351075243686	0	0	3.896442059232757	11.854255539839048	RARS2;MARS2;TARS2
N-glycan antennae elongation in the medial/trans-Golgi	2/20	0.04812526262493664	0.7298351075243686	0	0	6.195707070707071	18.797453256966755	ST6GAL1;ST8SIA6
Regulation of NFAT transcription factors	3/47	0.050332660604518284	0.7298351075243686	0	0	3.8076923076923075	11.3815772516685	DGKA;PRKCQ;IKZF1
S1P/S1P1 pathway	2/21	0.05258352597301863	0.7298351075243686	0	0	5.869318181818182	17.28721040916629	S1PR1;PLCB2
ChREBP regulation by carbohydrates and cAMP	2/21	0.05258352597301863	0.7298351075243686	0	0	5.869318181818182	17.28721040916629	PRKAG2;PRKACB
IGF1 signaling pathway	2/21	0.05258352597301863	0.7298351075243686	0	0	5.869318181818182	17.28721040916629	RASA1;IGF1R
Insulin signaling pathway	9/277	0.058927344082173816	0.7298351075243686	0	0	1.8862426995457495	5.3408019862730365	CYTH3;MAPK11;INSR;RASA1;PRKAG2;RHOH;PRKCQ;PRKACB;IGF1R
BAD phosphorylation mediated by IGF1R signaling	2/23	0.06191503149349049	0.7298351075243686	0	0	5.309794372294372	14.771807024633306	PRKACB;IGF1R
Mitochondrial pathway of apoptosis: antiapoptotic Bcl-2 family	2/23	0.06191503149349049	0.7298351075243686	0	0	5.309794372294372	14.771807024633306	AVEN;MAPK11
MicroRNAs in cardiomyocyte hypertrophy	4/85	0.06411810012649655	0.7298351075243686	0	0	2.7604938271604937	7.583155442670166	IL6ST;PLCB2;IGF1R;LRP6
Progesterone-mediated oocyte maturation	4/86	0.06635226897803462	0.7298351075243686	0	0	2.726689895470383	7.396902511691114	MAPK11;CDC23;PRKACB;IGF1R
Signal transduction of S1P receptor	2/24	0.06677577930858283	0.7298351075243686	0	0	5.068181818181818	13.716602532137205	S1PR1;PLCB2
PI3K pathway	3/53	0.06738695266068685	0.7298351075243686	0	0	3.3497435897435897	9.035276316317308	CYTH3;PIKFYVE;PRKCQ
Basigin interactions	2/25	0.0717584886027676	0.7298351075243686	0	0	4.847579051383399	12.770700381985021	ATP1B3;ITGA6
Salivary secretion	4/89	0.0732941836430151	0.7298351075243686	0	0	2.6300504201680672	6.873042442902384	ATP1B3;KCNN4;PRKACB;PLCB2
Physiological and pathological hypertrophy  of the heart	2/26	0.07685734729943974	0.7298351075243686	0	0	4.645359848484849	11.919083846216697	MAPK11;IL6ST
Inositol phosphate metabolism	3/57	0.08002563239490779	0.7298351075243686	0	0	3.1009813232035452	7.831243942894965	INPP4B;PIKFYVE;PLCB2
BAD phosphorylation regulation	2/27	0.08206670983138187	0.7298351075243686	0	0	4.4593181818181815	11.149289115179256	PRKACB;IGF1R
Cell cycle: G2/M checkpoint	2/27	0.08206670983138187	0.7298351075243686	0	0	4.4593181818181815	11.149289115179256	PRKDC;ATM
Control of gene expression by vitamin D receptor	2/27	0.08206670983138187	0.7298351075243686	0	0	4.4593181818181815	11.149289115179256	TOP2B;KAT2B
VEGFR1 pathway	2/27	0.08206670983138187	0.7298351075243686	0	0	4.4593181818181815	11.149289115179256	RASA1;CD2AP
AMPK inhibition of chREBP transcriptional activation activity	1/5	0.08543000918298997	0.7298351075243686	0	0	13.910764872521247	34.22128624523743	PRKAG2
CREB phosphorylation through the activation of adenylate cyclase	1/5	0.08543000918298997	0.7298351075243686	0	0	13.910764872521247	34.22128624523743	PRKACB
Insulin receptor substrate (IRS) activation	1/5	0.08543000918298997	0.7298351075243686	0	0	13.910764872521247	34.22128624523743	INSR
PKA-mediated phosphorylation of key metabolic factors	1/5	0.08543000918298997	0.7298351075243686	0	0	13.910764872521247	34.22128624523743	PRKACB
Multi-step regulation of transcription by PITX2	2/28	0.0873810930983562	0.7298351075243686	0	0	4.2875874125874125	10.45089289885289	LEF1;LRP6
PKB-mediated events	2/28	0.0873810930983562	0.7298351075243686	0	0	4.2875874125874125	10.45089289885289	CAB39L;PRKAG2
ADP-ribosylation factor	2/29	0.0927951724731506	0.7298351075243686	0	0	4.128577441077441	9.815117595575263	CYTH3;ASAP1
BARD1 signaling events	2/29	0.0927951724731506	0.7298351075243686	0	0	4.128577441077441	9.815117595575263	PRKDC;ATM
Skeletal myogenesis control by HDAC and calcium/calmodulin-dependent kinase (CaMK)	2/29	0.0927951724731506	0.7298351075243686	0	0	4.128577441077441	9.815117595575263	INSR;IGF1R
Thyroid cancer	2/29	0.0927951724731506	0.7298351075243686	0	0	4.128577441077441	9.815117595575263	LEF1;TCF7
Androgen receptor proteolysis and transcription regulation	3/61	0.09360652038562697	0.7298351075243686	0	0	2.8865310934276454	6.837196987415769	PRKDC;UBE3A;PATZ1
Wnt signaling pathway and pluripotency	4/98	0.09620722372475328	0.7298351075243686	0	0	2.3771428571428572	5.565487695481531	TCF7;LEF1;PRKCQ;LRP6
Adrenergic pathway	5/137	0.09652207274280307	0.7298351075243686	0	0	2.117956064947469	4.951746468499846	MAPK11;RGS14;PRKCQ;PRKACB;PLCB2
Retinoic acid receptor-mediated signaling	2/30	0.09830377799017932	0.7298351075243686	0	0	3.980925324675325	9.234523889819737	KAT2B;RARG
Inactivation of GSK3 by Akt causes accumulation of beta-catenin in alveolar macrophages	2/30	0.09830377799017932	0.7298351075243686	0	0	3.980925324675325	9.234523889819737	LEF1;LRP6
MicroRNAs in muscle cell differentiation	2/30	0.09830377799017932	0.7298351075243686	0	0	3.980925324675325	9.234523889819737	PRKCQ;PRKACB
Assembly of the ORC complex at the origin of replication	1/6	0.10162191839381594	0.7298351075243686	0	0	11.128045325779038	25.444231513381027	ORC5
Beta-oxidation of very long chain fatty acids	1/6	0.10162191839381594	0.7298351075243686	0	0	11.128045325779038	25.444231513381027	HSD17B4
Ras family activation regulation	2/31	0.10390189051774677	0.7298351075243686	0	0	3.8434561128526648	8.702769136909682	RASA1;RASGRP2
Angiotensin II-stimulated signaling through G-proteins and beta-arrestin	3/64	0.10436948081789331	0.7298351075243686	0	0	2.7441502031665967	6.2012799568641075	MAPK11;PRKCQ;PLCB2
Melanogenesis	4/101	0.10451004092753766	0.7298351075243686	0	0	2.3032695139911636	5.201869997770158	TCF7;LEF1;PRKACB;PLCB2
Fluoropyrimidine activity	2/33	0.11534729230106973	0.7298351075243686	0	0	3.595124633431085	7.764778111665327	ABCC4;ABCC5
cAMP cell motility pathway inferred from amoeba model	3/67	0.11559382758097791	0.7298351075243686	0	0	2.6151175213675213	5.64256773230436	DGKA;PRKACB;PLCB2
G alpha 13 pathway	3/67	0.11559382758097791	0.7298351075243686	0	0	2.6151175213675213	5.64256773230436	TBXA2R;ARHGEF18;PRKCQ
Fibroblast growth factor receptor pathway	4/105	0.11606832531629967	0.7298351075243686	0	0	2.2115983026874115	4.7628455790474895	CYTH3;MAPK11;PRKCQ;FGF13
Post-transcriptional silencing by small RNAs	1/7	0.11752795686800262	0.7298351075243686	0	0	9.27289896128423	19.85400963300396	TNRC6C
Wnt/LRP6 signaling	1/7	0.11752795686800262	0.7298351075243686	0	0	9.27289896128423	19.85400963300396	LRP6
AMPK signaling	3/68	0.11943247968500578	0.7298351075243686	0	0	2.5747534516765285	5.471361617750433	INSR;PRKAG2;PRKACB
G alpha i pathway	4/108	0.12508751428892256	0.7298351075243686	0	0	2.1474725274725275	4.464040633049887	MAPK11;RGS14;PRKCQ;PLCB2
Calcium regulation in the cardiac cell	5/149	0.12539466049780004	0.7298351075243686	0	0	1.9402658389048073	4.02855306747266	CACNB1;RGS14;ATP1B3;PRKCQ;PRKACB
Arf6 signal transduction regulation	2/35	0.12709410352107178	0.7298351075243686	0	0	3.3768939393939394	6.965949663521418	CYTH3;ACAP2
Integrated cancer pathway	2/35	0.12709410352107178	0.7298351075243686	0	0	3.3768939393939394	6.965949663521418	MSH2;ATM
G alpha q pathway	3/70	0.12724865058473148	0.7298351075243686	0	0	2.4976400051026917	5.1491651757863774	RGS14;PRKCQ;PLCB2
Transport to the Golgi and subsequent modification	2/36	0.13306949005096347	0.7298351075243686	0	0	3.2774064171122994	6.610147927109424	ST6GAL1;ST8SIA6
Beta-oxidation of pristanoyl-CoA	1/8	0.1331531570366007	0.7298351075243686	0	0	7.947794415216512	16.024782268271085	HSD17B4
Chromatin remodeling by nuclear receptors to facilitate initiation of transcription in carcinoma cells	1/8	0.1331531570366007	0.7298351075243686	0	0	7.947794415216512	16.024782268271085	KAT2B
Import of palmitoyl-CoA into the mitochondrial matrix	1/8	0.1331531570366007	0.7298351075243686	0	0	7.947794415216512	16.024782268271085	PRKAG2
Insulin secretion regulation by fatty acids bound to GPR40 (FFAR1)	1/8	0.1331531570366007	0.7298351075243686	0	0	7.947794415216512	16.024782268271085	PLCB2
Lysosphingolipid and lysophosphatidic acid (LPA) G-protein coupled receptors	1/8	0.1331531570366007	0.7298351075243686	0	0	7.947794415216512	16.024782268271085	S1PR1
Epidermal growth factor receptor (EGFR) pathway	4/111	0.13439311648510038	0.7298351075243686	0	0	2.0869425901201604	4.188464704826299	CYTH3;MAPK11;RHOH;PRKCQ
Gastric acid secretion	3/74	0.14340382018611383	0.7298351075243686	0	0	2.3564463705308776	4.576432607415515	ATP1B3;PRKACB;PLCB2
Polyadenylation of mRNA	1/9	0.14850246322339244	0.7298351075243686	0	0	6.953966005665722	13.262282230435094	PAPOLA
Prostanoid ligand receptors	1/9	0.14850246322339244	0.7298351075243686	0	0	6.953966005665722	13.262282230435094	TBXA2R
Rapid glucocorticoid receptor pathway	1/9	0.14850246322339244	0.7298351075243686	0	0	6.953966005665722	13.262282230435094	MAPK11
Calcium-activated potassium channels	1/9	0.14850246322339244	0.7298351075243686	0	0	6.953966005665722	13.262282230435094	KCNN4
Type I hemidesmosome assembly	1/9	0.14850246322339244	0.7298351075243686	0	0	6.953966005665722	13.262282230435094	ITGA6
West Nile virus infection	1/9	0.14850246322339244	0.7298351075243686	0	0	6.953966005665722	13.262282230435094	TIA1
G2/M DNA damage checkpoint	1/9	0.14850246322339244	0.7298351075243686	0	0	6.953966005665722	13.262282230435094	ATM
Aurora B signaling	2/39	0.15135367855652807	0.7298351075243686	0	0	3.0112100737100738	5.685573959581902	RASA1;SMC4
Platelet activation, signaling and aggregation	6/205	0.157111838165158	0.7298351075243686	0	0	1.6848899670767632	3.1183899404114284	ABCC4;TBXA2R;DGKA;PRKCQ;RASGRP2;DGKZ
Gastrin-CREB signaling pathway via PKC and MAPK	6/206	0.15959550867500646	0.7298351075243686	0	0	1.6763793103448277	3.0763450219365365	TBXA2R;DGKA;PRKCQ;RASGRP2;PLCB2;DGKZ
Activation of the AP-1 family of transcription factors	1/10	0.16358073307203908	0.7298351075243686	0	0	6.180988353792887	11.1903618987592	MAPK11
Apoptotic DNA fragmentation and tissue homeostasis	1/10	0.16358073307203908	0.7298351075243686	0	0	6.180988353792887	11.1903618987592	TOP2B
Rheb GTPase activity by AMPK regulation	1/10	0.16358073307203908	0.7298351075243686	0	0	6.180988353792887	11.1903618987592	PRKAG2
Cdc25 and Chk1 regulatory pathway in response to DNA damage	1/10	0.16358073307203908	0.7298351075243686	0	0	6.180988353792887	11.1903618987592	ATM
Splicing regulation through Sam68	1/10	0.16358073307203908	0.7298351075243686	0	0	6.180988353792887	11.1903618987592	RASA1
Taurine and hypotaurine metabolism	1/10	0.16358073307203908	0.7298351075243686	0	0	6.180988353792887	11.1903618987592	ADO
E2F-enabled inhibition of pre-replication complex formation	1/10	0.16358073307203908	0.7298351075243686	0	0	6.180988353792887	11.1903618987592	ORC5
Ethanol oxidation	1/10	0.16358073307203908	0.7298351075243686	0	0	6.180988353792887	11.1903618987592	ACSS1
Fanconi anemia pathway regulation	1/10	0.16358073307203908	0.7298351075243686	0	0	6.180988353792887	11.1903618987592	ATM
Insulin secretion regulation by acetylcholine	1/10	0.16358073307203908	0.7298351075243686	0	0	6.180988353792887	11.1903618987592	PLCB2
PIP biosynthesis at the late endosome membrane	1/10	0.16358073307203908	0.7298351075243686	0	0	6.180988353792887	11.1903618987592	PIKFYVE
Antigen presentation: folding, assembly, and peptide loading of class I MHC proteins	7/255	0.16771609488089972	0.7298351075243686	0	0	1.5778795203123548	2.8172764923388915	CDC23;ERAP1;HUWE1;ASB13;UBE4A;UBE3A;UBR1
Cardiac muscle contraction	3/80	0.16880349934961533	0.7298351075243686	0	0	2.172161172161172	3.864318095276771	CACNB1;ATP1B3;CACNA2D4
Aldosterone-regulated sodium reabsorption	2/42	0.170093433016401	0.7298351075243686	0	0	2.784943181818182	4.933268924456116	INSR;ATP1B3
Cell differentiation by G alpha (i/o) pathway inferred from mouse Neuro2A model	2/43	0.17642424506601728	0.7298351075243686	0	0	2.716879157427938	4.713415030684506	RASGRP2;PRKACB
G2/M checkpoints	2/43	0.17642424506601728	0.7298351075243686	0	0	2.716879157427938	4.713415030684506	ORC5;ATM
PI3K class IB pathway in neutrophils	2/43	0.17642424506601728	0.7298351075243686	0	0	2.716879157427938	4.713415030684506	PRKCQ;PRKACB
Alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	1/11	0.178392738967805	0.7298351075243686	0	0	5.562606232294618	9.588641287683966	HSD17B4
Attenuation of GPCR signaling	1/11	0.178392738967805	0.7298351075243686	0	0	5.562606232294618	9.588641287683966	PRKACB
Reversal of insulin resistance by leptin	1/11	0.178392738967805	0.7298351075243686	0	0	5.562606232294618	9.588641287683966	PRKAG2
SUMOylation as a mechanism to modulate CtBP-dependent gene responses	1/11	0.178392738967805	0.7298351075243686	0	0	5.562606232294618	9.588641287683966	UBE3A
CDC6 association with the ORC-origin complex	1/11	0.178392738967805	0.7298351075243686	0	0	5.562606232294618	9.588641287683966	ORC5
Stress fiber formation mediated by Rho-selective guanine exchange factor AKAP13	1/11	0.178392738967805	0.7298351075243686	0	0	5.562606232294618	9.588641287683966	PRKACB
Cystic fibrosis transmembrane conductance regulator (CFTR) and beta 2 adrenergic receptor (b2AR) pathway	1/11	0.178392738967805	0.7298351075243686	0	0	5.562606232294618	9.588641287683966	PRKACB
Down syndrome cell adhesion molecule (DSCAM) interactions	1/11	0.178392738967805	0.7298351075243686	0	0	5.562606232294618	9.588641287683966	MAPK11
Integrin beta-4 pathway	1/11	0.178392738967805	0.7298351075243686	0	0	5.562606232294618	9.588641287683966	ITGA6
Monocyte and its surface molecules	1/11	0.178392738967805	0.7298351075243686	0	0	5.562606232294618	9.588641287683966	SELL
Integration of energy metabolism	4/125	0.18120747407517163	0.7298351075243686	0	0	1.844155844155844	3.15002590489246	DPP4;PRKAG2;PRKACB;PLCB2
T cell signal transduction	3/83	0.18196056867090415	0.7298351075243686	0	0	2.0903846153846155	3.5619427877169367	MAPK11;PRKCQ;RASGRP2
Meiosis	3/83	0.18196056867090415	0.7298351075243686	0	0	2.0903846153846155	3.5619427877169367	DIDO1;ATM;MLH3
Vasopressin-regulated water reabsorption	2/44	0.18279146990732292	0.7298351075243686	0	0	2.652056277056277	4.506929060451591	NSF;PRKACB
G-protein-mediated events	2/44	0.18279146990732292	0.7298351075243686	0	0	2.652056277056277	4.506929060451591	PRKACB;PLCB2
Adaptive immune system	14/606	0.18909751545200226	0.7298351075243686	0	0	1.325298092209857	2.2072739562493817	ERAP1;HUWE1;ASB13;UBE4A;UBE3A;UBR1;RASGRP2;CDC23;SELL;IGHD;BTLA;PRKCQ;EVL;PRKACB
Phospholipase C epsilon pathway	1/12	0.19294316959658422	0.7298351075243686	0	0	5.056657223796034	8.320019464036454	PRKACB
Caspase-mediated cleavage of cytoskeletal proteins	1/12	0.19294316959658422	0.7298351075243686	0	0	5.056657223796034	8.320019464036454	ADD1
Gamma-aminobutyric acid receptor life cycle	1/12	0.19294316959658422	0.7298351075243686	0	0	5.056657223796034	8.320019464036454	NSF
Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	1/12	0.19294316959658422	0.7298351075243686	0	0	5.056657223796034	8.320019464036454	PRKACB
Opening of calcium channels triggered by depolarization of the presynaptic terminal	1/12	0.19294316959658422	0.7298351075243686	0	0	5.056657223796034	8.320019464036454	CACNB1
MAPK signaling pathway	8/314	0.19462117838354362	0.7298351075243686	0	0	1.4613321243719068	2.3917627041688263	CACNB1;MAPK11;RASA3;RASA1;CACNA2D4;RASGRP2;FGF13;PRKACB
ABC transporters	2/47	0.20207953799216713	0.7298351075243686	0	0	2.4748737373737373	3.957555513149113	ABCC4;ABCC5
Regulation of transcription by NOTCH1 intracellular domain	2/47	0.20207953799216713	0.7298351075243686	0	0	2.4748737373737373	3.957555513149113	KAT2B;HDAC10
Androgen receptor signaling, proteolysis, and transcription regulation	3/88	0.20446009933796272	0.7298351075243686	0	0	1.9669180492709903	3.122251164067121	KAT2B;UBE3A;PATZ1
Signal attenuation	1/13	0.2072366313221653	0.7298351075243686	0	0	4.635033050047214	7.295050670780774	INSR
Glucose-dependent insulinotropic polypeptide (GIP) biosynthesis, secretion, and inactivation	1/13	0.2072366313221653	0.7298351075243686	0	0	4.635033050047214	7.295050670780774	DPP4
NICD trafficking to the nucleus	1/13	0.2072366313221653	0.7298351075243686	0	0	4.635033050047214	7.295050670780774	KAT2B
ATM pathway	2/48	0.20856083725496988	0.7298351075243686	0	0	2.4209486166007905	3.794896257437365	MDC1;ATM
Lipid digestion, mobilization, and transport	2/48	0.20856083725496988	0.7298351075243686	0	0	2.4209486166007905	3.794896257437365	LDLRAP1;PRKACB
Prostate cancer	3/89	0.2090356553413091	0.7298351075243686	0	0	1.9439475253428742	3.0427647229734673	LEF1;TCF7;IGF1R
Hemostasis pathway	11/468	0.20939570232368773	0.7298351075243686	0	0	1.3465879005556582	2.105429912949681	DOCK11;ABCC4;SELL;TBXA2R;DGKA;PRKCQ;ATP1B3;ITGA6;RASGRP2;PRKACB;DGKZ
Glycerolipid metabolism	2/49	0.2150632584821227	0.7298351075243686	0	0	2.3693181818181817	3.6412228387475576	DGKA;DGKZ
Ubiquitin-mediated proteolysis	4/136	0.22122248865128352	0.7298351075243686	0	0	1.6895238095238094	2.5487925535072775	CDC23;HUWE1;UBE4A;UBE3A
Adhesion and diapedesis of lymphocytes	1/14	0.22127764963540655	0.7298351075243686	0	0	4.278274133798213	6.453079312472533	SELL
CARM1 transcriptional regulation by protein methylation	1/14	0.22127764963540655	0.7298351075243686	0	0	4.278274133798213	6.453079312472533	PRKACB
Hyaluronan metabolism	1/14	0.22127764963540655	0.7298351075243686	0	0	4.278274133798213	6.453079312472533	ABCC5
Intronless pre-mRNA processing	1/14	0.22127764963540655	0.7298351075243686	0	0	4.278274133798213	6.453079312472533	PAPOLA
Non-homologous end-joining (NHEJ) pathway	1/14	0.22127764963540655	0.7298351075243686	0	0	4.278274133798213	6.453079312472533	PRKDC
Phosphatidylinositol metabolism	2/50	0.2215840331594591	0.7298351075243686	0	0	2.319839015151515	3.495889243162455	INPP4B;PIKFYVE
Wnt signaling pathway	6/231	0.22670215748477573	0.7298351075243686	0	0	1.4881992337164751	2.2086635748278587	TCF7;LEF1;PRKCQ;PRKACB;PLCB2;LRP6
Cell surface interactions at the vascular wall	3/94	0.23223221915564884	0.7298351075243686	0	0	1.836667605898375	2.6815667788715154	SELL;ATP1B3;ITGA6
T cell receptor signaling pathway	4/139	0.23252230964124207	0.7298351075243686	0	0	1.6517248677248677	2.4094852038787145	MAPK11;RASA1;PRKCQ;ASAP1
Apoptotic execution  phase	2/52	0.23467002094422154	0.7298351075243686	0	0	2.226818181818182	3.2279397828600964	PRKCQ;ADD1
Taste transduction	2/52	0.23467002094422154	0.7298351075243686	0	0	2.226818181818182	3.2279397828600964	PRKACB;PLCB2
Endometrial cancer	2/52	0.23467002094422154	0.7298351075243686	0	0	2.226818181818182	3.2279397828600964	LEF1;TCF7
AKAP95 role in mitosis and chromosome dynamics	1/15	0.23507067062214784	0.7298351075243686	0	0	3.972480777013355	5.751632103803267	PRKACB
Adhesion and diapedesis of granulocytes	1/15	0.23507067062214784	0.7298351075243686	0	0	3.972480777013355	5.751632103803267	SELL
Association of licensing factors with the pre-replicative complex	1/15	0.23507067062214784	0.7298351075243686	0	0	3.972480777013355	5.751632103803267	ORC5
Repression of pain sensation by the transcriptional regulator DREAM	1/15	0.23507067062214784	0.7298351075243686	0	0	3.972480777013355	5.751632103803267	PRKACB
Bile acid and bile salt biosynthesis via 7-alpha-hydroxycholesterol	1/15	0.23507067062214784	0.7298351075243686	0	0	3.972480777013355	5.751632103803267	HSD17B4
Eicosanoid ligand-binding G-protein coupled receptors	1/15	0.23507067062214784	0.7298351075243686	0	0	3.972480777013355	5.751632103803267	TBXA2R
Mitochondrial pathway of apoptosis: BH3-only Bcl-2 family	3/97	0.2463675515042865	0.7298351075243686	0	0	1.7777777777777777	2.4905435490101633	CAPN3;PRKCQ;PRKACB
Transmission across chemical synapses	5/190	0.2473216066834338	0.7298351075243686	0	0	1.5070858824440487	2.1054980504926317	NSF;CACNB1;GABRR2;PRKACB;PLCB2
Meiotic recombination	2/54	0.24779842848329436	0.7298351075243686	0	0	2.140952797202797	2.986928139758249	ATM;MLH3
Primary bile acid biosynthesis	1/16	0.24862006219102842	0.7298351075243686	0	0	3.707459867799811	5.16015165249498	HSD17B4
Protein kinase A (PKA) at the centrosome	1/16	0.24862006219102842	0.7298351075243686	0	0	3.707459867799811	5.16015165249498	PRKACB
Rb tumor suppressor/checkpoint signaling in response to DNA damage	1/16	0.24862006219102842	0.7298351075243686	0	0	3.707459867799811	5.16015165249498	ATM
Riboflavin metabolism	1/16	0.24862006219102842	0.7298351075243686	0	0	3.707459867799811	5.16015165249498	ACP6
Sonic Hedgehog (Shh) pathway	1/16	0.24862006219102842	0.7298351075243686	0	0	3.707459867799811	5.16015165249498	PRKACB
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	1/16	0.24862006219102842	0.7298351075243686	0	0	3.707459867799811	5.16015165249498	ARHGEF18
DNA-PK pathway in nonhomologous end joining	1/16	0.24862006219102842	0.7298351075243686	0	0	3.707459867799811	5.16015165249498	PRKDC
GluR2-containing AMPA receptor trafficking	1/16	0.24862006219102842	0.7298351075243686	0	0	3.707459867799811	5.16015165249498	NSF
Inhibitor of DNA binding (ID) signaling pathway	1/16	0.24862006219102842	0.7298351075243686	0	0	3.707459867799811	5.16015165249498	ID3
Basal cell carcinoma	2/55	0.2543725429180484	0.7298351075243686	0	0	2.10045025728988	2.8754226845968494	LEF1;TCF7
T cell receptor signaling in naive CD8+ T cells	2/55	0.2543725429180484	0.7298351075243686	0	0	2.10045025728988	2.8754226845968494	PRKCQ;RASGRP2
Apoptotic cleavage of cellular proteins	1/17	0.26193011567077507	0.7298351075243686	0	0	3.4755665722379603	4.656138492569398	PRKCQ
SHC-related events	1/17	0.26193011567077507	0.7298351075243686	0	0	3.4755665722379603	4.656138492569398	INSR
Beta-catenin phosphorylation cascade	1/17	0.26193011567077507	0.7298351075243686	0	0	3.4755665722379603	4.656138492569398	AMER1
Chylomicron-mediated lipid transport	1/17	0.26193011567077507	0.7298351075243686	0	0	3.4755665722379603	4.656138492569398	LDLRAP1
Synaptic proteins at the synaptic junction	1/17	0.26193011567077507	0.7298351075243686	0	0	3.4755665722379603	4.656138492569398	ADD1
TAK1-mediated activation of p38 MAPK	1/17	0.26193011567077507	0.7298351075243686	0	0	3.4755665722379603	4.656138492569398	MAPK11
Destabilization of mRNA by KSRP	1/17	0.26193011567077507	0.7298351075243686	0	0	3.4755665722379603	4.656138492569398	MAPK11
PIP biosynthesis at the Golgi membrane	1/17	0.26193011567077507	0.7298351075243686	0	0	3.4755665722379603	4.656138492569398	PIKFYVE
GnRH signaling pathway	3/101	0.26541181003123293	0.7298351075243686	0	0	1.7048665620094192	2.261458881896749	MAPK11;PRKACB;PLCB2
Acute myeloid leukemia	2/57	0.26752930478382286	0.7298351075243686	0	0	2.0238636363636364	2.6685171651154924	LEF1;TCF7
Pre-NOTCH expression and processing	2/57	0.26752930478382286	0.7298351075243686	0	0	2.0238636363636364	2.6685171651154924	TNRC6C;KAT2B
SHP2 signaling	2/57	0.26752930478382286	0.7298351075243686	0	0	2.0238636363636364	2.6685171651154924	IL6ST;IGF1R
Mechanism of gene regulation by peroxisome proliferators via PPAR-alpha	2/57	0.26752930478382286	0.7298351075243686	0	0	2.0238636363636364	2.6685171651154924	HSD17B4;PRKACB
HIV-1 Nef as negative effector of Fas and TNF	2/58	0.27410766858335556	0.7298351075243686	0	0	1.9876217532467533	2.5724482459835416	PRKDC;RASA1
CDK regulation of DNA replication	1/18	0.2750050469474737	0.7298351075243686	0	0	3.2709548408598565	4.222690927581148	ORC5
Nucleotide di- and triphosphate biosynthesis and interconversion	1/18	0.2750050469474737	0.7298351075243686	0	0	3.2709548408598565	4.222690927581148	CTPS2
PKA activation in glucagon signaling	1/18	0.2750050469474737	0.7298351075243686	0	0	3.2709548408598565	4.222690927581148	PRKACB
RNA degradation	2/59	0.2806832893105505	0.7298351075243686	0	0	1.9526515151515151	2.4808990678161584	XRN2;PAPOLA
DNA repair	3/105	0.28462506038641144	0.7298351075243686	0	0	1.6376738729679907	2.0578723989766856	MDC1;PRKDC;ATM
Signaling by FGFR1 fusion mutants	1/19	0.28784899781787976	0.7298351075243686	0	0	3.0890777463015424	3.846887980605738	ZMYM2
Cell cycle progression regulation by PLK3	1/19	0.28784899781787976	0.7298351075243686	0	0	3.0890777463015424	3.846887980605738	ATM
TP53 network	1/19	0.28784899781787976	0.7298351075243686	0	0	3.0890777463015424	3.846887980605738	ATM
Telomeres, telomerase, cellular aging, and immortality	1/19	0.28784899781787976	0.7298351075243686	0	0	3.0890777463015424	3.846887980605738	IGF1R
G-protein-independent seven transmembrane receptor signaling	1/19	0.28784899781787976	0.7298351075243686	0	0	3.0890777463015424	3.846887980605738	MAPK11
IGF-1 receptor and longevity	1/19	0.28784899781787976	0.7298351075243686	0	0	3.0890777463015424	3.846887980605738	IGF1R
Inhibition of T cell receptor signaling by activated Csk	1/19	0.28784899781787976	0.7298351075243686	0	0	3.0890777463015424	3.846887980605738	PRKACB
Lissencephaly gene (LIS1) in neuronal migration and development	1/19	0.28784899781787976	0.7298351075243686	0	0	3.0890777463015424	3.846887980605738	DNAH8
Integrin signaling pathway	4/155	0.2947635649003267	0.7298351075243686	0	0	1.4754966887417218	1.8024397812779434	MAPK11;CAPN3;RHOH;ASAP1
Myometrial relaxation and contraction pathways	4/155	0.2947635649003267	0.7298351075243686	0	0	1.4754966887417218	1.8024397812779434	RGS14;PRKCQ;PRKACB;DGKZ
Shigellosis	2/62	0.30037445324172657	0.7298351075243686	0	0	1.8547348484848485	2.230736722144336	MAPK11;ARPC5L
Signaling events mediated by focal adhesion kinase	2/62	0.30037445324172657	0.7298351075243686	0	0	1.8547348484848485	2.230736722144336	RASA1;ASAP1
Peroxisomal lipid metabolism	1/20	0.30046603743206485	0.7298351075243686	0	0	2.9263456090651556	3.5186981013861267	HSD17B4
Apoptotic signaling in response to DNA damage	1/20	0.30046603743206485	0.7298351075243686	0	0	2.9263456090651556	3.5186981013861267	ATM
Skeletal muscle hypertrophy is regulated via AKT/mTOR pathway	1/20	0.30046603743206485	0.7298351075243686	0	0	2.9263456090651556	3.5186981013861267	IGF1R
Sprouty regulation of tyrosine kinase signals	1/20	0.30046603743206485	0.7298351075243686	0	0	2.9263456090651556	3.5186981013861267	RASA1
GATA3-mediated activation of Th2 cytokine expression	1/20	0.30046603743206485	0.7298351075243686	0	0	2.9263456090651556	3.5186981013861267	PRKACB
ID regulation of gene expression	1/20	0.30046603743206485	0.7298351075243686	0	0	2.9263456090651556	3.5186981013861267	ITGA6
Signaling by insulin receptor	3/109	0.30394894071210854	0.7298351075243686	0	0	1.5755523302693113	1.8763182586992397	CAB39L;INSR;PRKAG2
APC/C activator regulation between G1/S and early anaphase	1/21	0.31286016337895006	0.7298351075243686	0	0	2.779886685552408	3.2302254115033233	CDC23
Presynaptic function of kainate receptors	1/21	0.31286016337895006	0.7298351075243686	0	0	2.779886685552408	3.2302254115033233	PLCB2
p38 MK2 pathway	1/21	0.31286016337895006	0.7298351075243686	0	0	2.779886685552408	3.2302254115033233	MAPK11
Inactivation of APC/C via direct inhibition of the APC/C complex	1/21	0.31286016337895006	0.7298351075243686	0	0	2.779886685552408	3.2302254115033233	CDC23
Endothelins	2/64	0.31345409752261066	0.7298351075243686	0	0	1.7947214076246334	2.082060520813093	PRKCQ;PLCB2
Antigen-activated B-cell receptor generation of second messengers	5/211	0.31872633632681857	0.7298351075243686	0	0	1.3519904303558017	1.5458961754267617	MAPK11;RASA1;IGHD;PRKCQ;GTF2I
ERK1/ERK2 MAPK pathway	2/65	0.319974507062947	0.7298351075243686	0	0	1.7661435786435786	2.0125452487288786	PRKACB;IGF1R
Oocyte meiosis	3/113	0.32332848797622615	0.7298351075243686	0	0	1.5179487179487179	1.713895377661897	CDC23;PRKACB;IGF1R
BRCA1, BRCA2 and ATR roles in cancer susceptibility	1/22	0.32503530305898537	0.7298351075243686	0	0	2.647376230945636	2.975178268034171	ATM
T cell receptor downstream signaling	1/22	0.32503530305898537	0.7298351075243686	0	0	2.647376230945636	2.975178268034171	PRKCQ
Fanconi anemia pathway	1/22	0.32503530305898537	0.7298351075243686	0	0	2.647376230945636	2.975178268034171	ATM
Nephrin interactions	1/22	0.32503530305898537	0.7298351075243686	0	0	2.647376230945636	2.975178268034171	CD2AP
Nitric oxide signaling pathway	1/22	0.32503530305898537	0.7298351075243686	0	0	2.647376230945636	2.975178268034171	PRKACB
Signaling by TGF-beta receptor complex	2/66	0.32647986569712184	0.7298351075243686	0	0	1.7384588068181819	1.9460081870856742	ARHGEF18;MEN1
Adipocytokine signaling pathway	2/67	0.3329686660833368	0.7298351075243686	0	0	1.711625874125874	1.8822867656372604	PRKAG2;PRKCQ
T cell receptor signaling in naive CD4+ T cells	2/67	0.3329686660833368	0.7298351075243686	0	0	1.711625874125874	1.8822867656372604	PRKCQ;RASGRP2
Telomerase regulation	2/67	0.3329686660833368	0.7298351075243686	0	0	1.711625874125874	1.8822867656372604	UBE3A;ATM
G1 to S cell cycle control	2/67	0.3329686660833368	0.7298351075243686	0	0	1.711625874125874	1.8822867656372604	ORC5;ATM
Interleukin-4 regulation of apoptosis	6/267	0.3352851499681145	0.7298351075243686	0	0	1.2805522526093276	1.3993540988077413	ST6GAL1;CHST10;TCF7;S1PR1;ID3;SSBP2
Post-elongation processing of intronless pre-mRNA	1/23	0.33699531486443285	0.7298351075243686	0	0	2.5269121813031163	2.748487637607967	PAPOLA
Progesterone-initiated oocyte maturation	1/23	0.33699531486443285	0.7298351075243686	0	0	2.5269121813031163	2.748487637607967	PRKACB
Proximal tubule bicarbonate reclamation	1/23	0.33699531486443285	0.7298351075243686	0	0	2.5269121813031163	2.748487637607967	ATP1B3
CREB transcription factor and its extracellular signals	1/23	0.33699531486443285	0.7298351075243686	0	0	2.5269121813031163	2.748487637607967	PRKACB
Eicosanoid metabolism	1/23	0.33699531486443285	0.7298351075243686	0	0	2.5269121813031163	2.748487637607967	TBXA2R
Hypoxia and p53 in the cardiovascular system	1/23	0.33699531486443285	0.7298351075243686	0	0	2.5269121813031163	2.748487637607967	ATM
Incretin biosynthesis, secretion, and inactivation	1/23	0.33699531486443285	0.7298351075243686	0	0	2.5269121813031163	2.748487637607967	DPP4
Vascular smooth muscle contraction	3/116	0.3378685720319732	0.7298351075243686	0	0	1.4774222827320171	1.6031484062800685	PRKCQ;PRKACB;PLCB2
Cell cycle checkpoints	3/117	0.34271220900880817	0.7298351075243686	0	0	1.4643874643874644	1.568160146856046	ORC5;CDC23;ATM
Prolactin regulation of apoptosis	3/118	0.34755309007551966	0.7298351075243686	0	0	1.4515793385358602	1.53408398499387	ZSCAN26;BACH2;RALGPS2
p53 activity regulation	3/118	0.34755309007551966	0.7298351075243686	0	0	1.4515793385358602	1.53408398499387	KAT2B;HUWE1;ATM
Plexin D1 signaling	1/24	0.34874398934966194	0.7298351075243686	0	0	2.4169232664121196	2.5460284935978	ITGA6
Proteasome complex	1/24	0.34874398934966194	0.7298351075243686	0	0	2.4169232664121196	2.5460284935978	UBE3A
Tumor suppressor Arf inhibits ribosomal biogenesis	1/24	0.34874398934966194	0.7298351075243686	0	0	2.4169232664121196	2.5460284935978	ATM
Endogenous Toll-like receptor signaling	1/24	0.34874398934966194	0.7298351075243686	0	0	2.4169232664121196	2.5460284935978	TLR1
Signaling events mediated by HDAC class I	2/70	0.3523215022599967	0.7298351075243686	0	0	1.6358622994652405	1.7065498095595326	KAT2B;HDAC10
Hedgehog signaling pathway	2/70	0.3523215022599967	0.7298351075243686	0	0	1.6358622994652405	1.7065498095595326	IFT172;PRKACB
Long-term depression	2/70	0.3523215022599967	0.7298351075243686	0	0	1.6358622994652405	1.7065498095595326	PLCB2;IGF1R
Long-term potentiation	2/70	0.3523215022599967	0.7298351075243686	0	0	1.6358622994652405	1.7065498095595326	PRKACB;PLCB2
Signaling by NOTCH	3/119	0.35239049943834216	0.7298351075243686	0	0	1.4389920424403182	1.5008907814248984	TNRC6C;KAT2B;HDAC10
Pathways in cancer	7/325	0.35329644992886955	0.7298351075243686	0	0	1.226106972613416	1.2757002690989718	MSH2;MSH3;TCF7;LEF1;ITGA6;FGF13;IGF1R
Transmembrane transport of small molecules	9/432	0.3572069269491943	0.7298351075243686	0	0	1.1855072463768115	1.2204086245375585	GABRR2;ABCC4;ATP8A1;ABCC5;ATP11C;ATP1B3;SLC12A6;SLC12A7;PRKACB
G alpha s pathway	3/120	0.35722373498775656	0.7298351075243686	0	0	1.426619913799401	1.4685525313169436	MAPK11;RGS14;PRKACB
Bacterial invasion of epithelial cells	2/71	0.3587301289895977	0.7298351075243686	0	0	1.6120718050065876	1.652671677074375	ARPC5L;CD2AP
Interleukin-6 signaling pathway	2/71	0.3587301289895977	0.7298351075243686	0	0	1.6120718050065876	1.652671677074375	MAPK11;IL6ST
Melanoma	2/71	0.3587301289895977	0.7298351075243686	0	0	1.6120718050065876	1.652671677074375	FGF13;IGF1R
Mitochondrial pathway of apoptosis: multidomain Bcl-2 family	2/71	0.3587301289895977	0.7298351075243686	0	0	1.6120718050065876	1.652671677074375	CAPN3;PRKCQ
APC/C- and Cdc20-mediated degradation of Nek2A	1/25	0.3602850505843202	0.7298351075243686	0	0	2.3161000944287062	2.3644133718671596	CDC23
RNA polymerase I transcription initiation	1/25	0.3602850505843202	0.7298351075243686	0	0	2.3161000944287062	2.3644133718671596	KAT2B
Regulatory RNA pathways	1/25	0.3602850505843202	0.7298351075243686	0	0	2.3161000944287062	2.3644133718671596	TNRC6C
Ck1/Cdk5 regulation by type 1 glutamate receptors	1/25	0.3602850505843202	0.7298351075243686	0	0	2.3161000944287062	2.3644133718671596	PRKACB
TPO signaling pathway	1/25	0.3602850505843202	0.7298351075243686	0	0	2.3161000944287062	2.3644133718671596	RASA1
DARPP-32 events	1/25	0.3602850505843202	0.7298351075243686	0	0	2.3161000944287062	2.3644133718671596	PRKACB
Ligand-gated ion channel transport	1/25	0.3602850505843202	0.7298351075243686	0	0	2.3161000944287062	2.3644133718671596	GABRR2
Signaling by NOTCH1	2/73	0.3714764222820734	0.7298351075243686	0	0	1.5665012804097311	1.5512590398346784	KAT2B;HDAC10
RXR/VDR pathway	1/26	0.3716221570860812	0.7298351075243686	0	0	2.223342776203966	2.200837317220621	RARG
Segmentation clock	1/26	0.3716221570860812	0.7298351075243686	0	0	2.223342776203966	2.200837317220621	LRP6
Selenoamino acid metabolism	1/26	0.3716221570860812	0.7298351075243686	0	0	2.223342776203966	2.200837317220621	MARS2
Steroid biosynthesis	1/26	0.3716221570860812	0.7298351075243686	0	0	2.223342776203966	2.200837317220621	HSD17B4
Termination of O-glycan biosynthesis	1/26	0.3716221570860812	0.7298351075243686	0	0	2.223342776203966	2.200837317220621	ST6GAL1
ERBB2 role in signal transduction and oncology	1/26	0.3716221570860812	0.7298351075243686	0	0	2.223342776203966	2.200837317220621	IL6ST
YAP1- and WWTR1 (TAZ)-stimulated gene expression	1/26	0.3716221570860812	0.7298351075243686	0	0	2.223342776203966	2.200837317220621	KAT2B
Fibroblast growth factor 1	1/26	0.3716221570860812	0.7298351075243686	0	0	2.223342776203966	2.200837317220621	IGF1R
Inhibition of activated T cell apoptosis by neuropeptides VIP and PACAP	1/26	0.3716221570860812	0.7298351075243686	0	0	2.223342776203966	2.200837317220621	PRKACB
Integrin family cell surface interactions	1/26	0.3716221570860812	0.7298351075243686	0	0	2.223342776203966	2.200837317220621	ITGA6
Interleukin-27-mediated signaling events	1/26	0.3716221570860812	0.7298351075243686	0	0	2.223342776203966	2.200837317220621	IL6ST
Interleukin-9 regulation of target genes	1/26	0.3716221570860812	0.7298351075243686	0	0	2.223342776203966	2.200837317220621	SELL
Rho GTPase cycle	3/123	0.37169158059564517	0.7298351075243686	0	0	1.3907407407407408	1.3764033900192838	ARHGEF18;RHOH;GMIP
E2F transcription factor network	2/74	0.37781177094947316	0.7298351075243686	0	0	1.544665404040404	1.5035142322636155	KAT2B;ATM
Wnt/calcium/cyclic GMP pathway	2/74	0.37781177094947316	0.7298351075243686	0	0	1.544665404040404	1.5035142322636155	PRKCQ;PLCB2
T cell receptor regulation of apoptosis	12/603	0.3807733796841997	0.7298351075243686	0	0	1.1312969394722	1.0923247608788895	TLR1;ZBTB18;AVEN;ZMYM2;XRN2;LEF1;ERAP1;HUWE1;RHOH;ATM;CEP97;RASGRP2
ADP signalling through P2Y purinoceptor 12	1/27	0.3827589030698481	0.7298351075243686	0	0	2.1377206363042056	2.0529599786967845	PLCB2
Bile acid and bile salt metabolism	1/27	0.3827589030698481	0.7298351075243686	0	0	2.1377206363042056	2.0529599786967845	HSD17B4
Collecting duct acid secretion	1/27	0.3827589030698481	0.7298351075243686	0	0	2.1377206363042056	2.0529599786967845	SLC12A7
EGFR downregulation	1/27	0.3827589030698481	0.7298351075243686	0	0	2.1377206363042056	2.0529599786967845	EPS15L1
Insulin regulation of blood glucose	1/27	0.3827589030698481	0.7298351075243686	0	0	2.1377206363042056	2.0529599786967845	INSR
Mammalian calpain regulation of cell motility	1/27	0.3827589030698481	0.7298351075243686	0	0	2.1377206363042056	2.0529599786967845	PRKACB
Glycolysis and gluconeogenesis	2/75	0.38412045586688137	0.7298351075243686	0	0	1.5234277708592776	1.4576143024480206	ADPGK;ACSS1
Neuronal system	6/283	0.3856307390733573	0.7298351075243686	0	0	1.2055894435453753	1.1487760433199208	NSF;CACNB1;GABRR2;KCNN4;PRKACB;PLCB2
Cell cycle: G1/S checkpoint	1/28	0.39369881977601756	0.7298351075243686	0	0	2.058440877137761	1.9188149362301623	ATM
G-protein beta-gamma signalling	1/28	0.39369881977601756	0.7298351075243686	0	0	2.058440877137761	1.9188149362301623	PLCB2
G alpha (12/13) signaling events	2/77	0.3966537168787027	0.7298351075243686	0	0	1.4826515151515152	1.3709954441944698	TBXA2R;ARHGEF18
Cell-cell communication	3/129	0.4004258597079772	0.7298351075243686	0	0	1.3241079907746574	1.2118589192331068	MAPK11;ITGA6;CD2AP
Association of TriC/CCT with target proteins during biosynthesis	1/29	0.40444537611347386	0.7298351075243686	0	0	1.9848239579117766	1.7967392452521151	XRN2
S1P/S1P3 pathway	1/29	0.40444537611347386	0.7298351075243686	0	0	1.9848239579117766	1.7967392452521151	S1PR1
CDO in myogenesis	1/29	0.40444537611347386	0.7298351075243686	0	0	1.9848239579117766	1.7967392452521151	MAPK11
Statin pathway	1/29	0.40444537611347386	0.7298351075243686	0	0	1.9848239579117766	1.7967392452521151	ACSS1
Transferrin endocytosis and recycling	1/29	0.40444537611347386	0.7298351075243686	0	0	1.9848239579117766	1.7967392452521151	INSR
Homologous recombination	1/29	0.40444537611347386	0.7298351075243686	0	0	1.9848239579117766	1.7967392452521151	ATM
IGF1 pathway	1/29	0.40444537611347386	0.7298351075243686	0	0	1.9848239579117766	1.7967392452521151	IGF1R
Lipoprotein metabolism	1/29	0.40444537611347386	0.7298351075243686	0	0	1.9848239579117766	1.7967392452521151	LDLRAP1
p73 transcription factor network	2/79	0.4090684120280579	0.7298351075243686	0	0	1.4439935064935066	1.2907466204226967	MAPK11;PRKACB
Glycerophospholipid metabolism	2/79	0.4090684120280579	0.7298351075243686	0	0	1.4439935064935066	1.2907466204226967	DGKA;DGKZ
Activation of kainate receptors upon glutamate binding	1/30	0.4150019802043119	0.7298351075243686	0	0	1.9162840675979291	1.685318156943543	PLCB2
Activation of the pre-replicative complex	1/30	0.4150019802043119	0.7298351075243686	0	0	1.9162840675979291	1.685318156943543	ORC5
CDC42 activity regulation	1/30	0.4150019802043119	0.7298351075243686	0	0	1.9162840675979291	1.685318156943543	DOCK11
Signaling by FGFR1 mutants	1/30	0.4150019802043119	0.7298351075243686	0	0	1.9162840675979291	1.685318156943543	ZMYM2
Signaling pathway from G-protein families	1/30	0.4150019802043119	0.7298351075243686	0	0	1.9162840675979291	1.685318156943543	PRKACB
TNFR1 signaling pathway	1/30	0.4150019802043119	0.7298351075243686	0	0	1.9162840675979291	1.685318156943543	PRKDC
p38-alpha and p38-beta regulation	1/30	0.4150019802043119	0.7298351075243686	0	0	1.9162840675979291	1.685318156943543	MAPK11
Glutamate binding and activation of AMPA receptors and synaptic plasticity	1/30	0.4150019802043119	0.7298351075243686	0	0	1.9162840675979291	1.685318156943543	NSF
Interferon-beta enhancer pathway	1/30	0.4150019802043119	0.7298351075243686	0	0	1.9162840675979291	1.685318156943543	KAT2B
Nuclear events mediated by MAP kinases	1/30	0.4150019802043119	0.7298351075243686	0	0	1.9162840675979291	1.685318156943543	MAPK11
Ovarian infertility genes	1/30	0.4150019802043119	0.7298351075243686	0	0	1.9162840675979291	1.685318156943543	ATM
PDGFA signaling pathway	1/30	0.4150019802043119	0.7298351075243686	0	0	1.9162840675979291	1.685318156943543	RASA1
Nuclear beta-catenin signaling and target gene transcription regulation	2/80	0.41522904895801777	0.7298351075243686	0	0	1.4254079254079255	1.2528266406070485	LEF1;TCF7
Opioid signaling	2/80	0.41522904895801777	0.7298351075243686	0	0	1.4254079254079255	1.2528266406070485	PRKACB;PLCB2
Alpha-6 beta-4 integrin signaling pathway	1/31	0.42537198022543804	0.7311356161995186	0	0	1.8523135033050047	1.5833413661284401	ITGA6
Signal amplification	1/31	0.42537198022543804	0.7311356161995186	0	0	1.8523135033050047	1.5833413661284401	TBXA2R
CD40/CD40L signaling	1/31	0.42537198022543804	0.7311356161995186	0	0	1.8523135033050047	1.5833413661284401	MAPK11
Stathmin and breast cancer resistance to antimicrotubule agents	1/31	0.42537198022543804	0.7311356161995186	0	0	1.8523135033050047	1.5833413661284401	PRKACB
Gluconeogenesis	1/31	0.42537198022543804	0.7311356161995186	0	0	1.8523135033050047	1.5833413661284401	PRKACB
NF-kappaB activation by non-typeable Hemophilus influenzae	1/31	0.42537198022543804	0.7311356161995186	0	0	1.8523135033050047	1.5833413661284401	MAPK11
Apoptosis	5/242	0.4271519120155694	0.7311356161995186	0	0	1.1732738505434455	0.9980049971429134	PRKCQ;ATM;PRKACB;ADD1;IGF1R
ATM-dependent DNA damage response	2/82	0.4274527599072229	0.7311356161995186	0	0	1.3896306818181818	1.181063097024786	INSR;ATM
Regular glucocorticoid receptor pathway	2/82	0.4274527599072229	0.7311356161995186	0	0	1.3896306818181818	1.181063097024786	MAPK11;PRKACB
Alpha-synuclein signaling	1/32	0.4355586655653341	0.7400257923254404	0	0	1.792470072192269	1.489768092668509	PLCB2
Signaling by Robo receptor	1/32	0.4355586655653341	0.7400257923254404	0	0	1.792470072192269	1.489768092668509	EVL
Differentiation pathway in PC12 cells	2/84	0.4395413141111587	0.7400257923254404	0	0	1.35559866962306	1.1143340494137415	PRKACB;PLCB2
Asparagine N-linked glycosylation	2/85	0.4455331430576924	0.7400257923254404	0	0	1.3391976998904709	1.0827194306146457	ST6GAL1;ST8SIA6
Integrin cell surface interactions	2/85	0.4455331430576924	0.7400257923254404	0	0	1.3391976998904709	1.0827194306146457	ITGA6;RASGRP2
Propanoate metabolism	1/33	0.44556526763050075	0.7400257923254404	0	0	1.7363668555240792	1.4036990012150425	ACSS1
Syndecan 2 pathway	1/33	0.44556526763050075	0.7400257923254404	0	0	1.7363668555240792	1.4036990012150425	RASA1
E2F-mediated regulation of DNA replication	1/33	0.44556526763050075	0.7400257923254404	0	0	1.7363668555240792	1.4036990012150425	ORC5
Glucagon signaling in metabolic regulation	1/33	0.44556526763050075	0.7400257923254404	0	0	1.7363668555240792	1.4036990012150425	PRKACB
PIP biosynthesis at the plasma membrane	1/33	0.44556526763050075	0.7400257923254404	0	0	1.7363668555240792	1.4036990012150425	INPP4B
Non-class A, B, C GPCRs	2/86	0.45148913622330245	0.7476106171567141	0	0	1.3231872294372293	1.052203735170072	S1PR1;GPR83
TOR signaling	1/34	0.4553949611457212	0.7476106171567141	0	0	1.6836638338054768	1.3243534550832856	PRKAG2
EPO receptor signaling	1/34	0.4553949611457212	0.7476106171567141	0	0	1.6836638338054768	1.3243534550832856	RASA1
Nuclear receptors in lipid metabolism and toxicity	1/34	0.4553949611457212	0.7476106171567141	0	0	1.6836638338054768	1.3243534550832856	RARG
EGF/EGFR signaling pathway	3/141	0.456655699833944	0.7476106171567141	0	0	1.208224947355382	0.9470376008946769	ATXN2;RASA1;EPS15L1
Prion diseases	1/35	0.465050865063922	0.7506313962862742	0	0	1.6340609898350276	1.251050970497109	PRKACB
Basal transcription factors	1/35	0.465050865063922	0.7506313962862742	0	0	1.6340609898350276	1.251050970497109	GTF2I
Cytokines and inflammatory response	1/35	0.465050865063922	0.7506313962862742	0	0	1.6340609898350276	1.251050970497109	IL16
EGF receptor (ErbB1) signaling pathway	1/35	0.465050865063922	0.7506313962862742	0	0	1.6340609898350276	1.251050970497109	RASA1
PIK3C1/AKT pathway	1/35	0.465050865063922	0.7506313962862742	0	0	1.6340609898350276	1.251050970497109	PRKDC
Interleukin-5 regulation of apoptosis	3/144	0.4703768036792898	0.7538569364164621	0	0	1.1823361823361824	0.8917430089479869	TLR1;RHOH;ITGA6
Phospholipids as signaling intermediaries	1/36	0.47453604339044186	0.7538569364164621	0	0	1.5872925940914608	1.1831959995342332	S1PR1
Signaling to ERKs	1/36	0.47453604339044186	0.7538569364164621	0	0	1.5872925940914608	1.1831959995342332	MAPK11
GM-CSF-mediated signaling events	1/36	0.47453604339044186	0.7538569364164621	0	0	1.5872925940914608	1.1831959995342332	PRKACB
Generation of second messenger molecules	1/36	0.47453604339044186	0.7538569364164621	0	0	1.5872925940914608	1.1831959995342332	EVL
Gap junction pathway	2/90	0.474943026258888	0.7538569364164621	0	0	1.2627840909090908	0.9402190617587459	PRKACB;PLCB2
Endocytosis	4/201	0.47741753496563616	0.7556912915340042	0	0	1.1282958665699783	0.8342211596198418	ACAP2;ASAP1;LDLRAP1;IGF1R
Activation of NMDA receptor upon glutamate binding and postsynaptic events	1/37	0.4838535063366214	0.7614965977651602	0	0	1.5431224425558703	1.1202653693186988	PRKACB
Platelet aggregation (plug formation)	1/37	0.4838535063366214	0.7614965977651602	0	0	1.5431224425558703	1.1202653693186988	RASGRP2
Messenger RNA processing	4/203	0.48507200381201304	0.7614965977651602	0	0	1.1168413496051688	0.8079877394071756	METTL3;XRN2;PAPOLA;SRPK1
Signaling events mediated by HDAC class II	1/38	0.49300621109465204	0.7634934025871233	0	0	1.5013398667789604	1.0617978583545609	HDAC10
Signaling of hepatocyte growth factor receptor	1/38	0.49300621109465204	0.7634934025871233	0	0	1.5013398667789604	1.0617978583545609	RASA1
EGFR interaction with phospholipase C-gamma	1/38	0.49300621109465204	0.7634934025871233	0	0	1.5013398667789604	1.0617978583545609	PRKACB
p38 alpha/beta MAPK downstream pathway	1/38	0.49300621109465204	0.7634934025871233	0	0	1.5013398667789604	1.0617978583545609	MAPK11
Nuclear receptors	1/38	0.49300621109465204	0.7634934025871233	0	0	1.5013398667789604	1.0617978583545609	RARG
Fc gamma receptor-mediated phagocytosis	2/94	0.49778036494817596	0.767134368827468	0	0	1.207633399209486	0.8424406314793045	ARPC5L;ASAP1
Signaling events regulated by Ret tyrosine kinase	1/39	0.5019970629700183	0.767134368827468	0	0	1.461756373937677	1.0073854989854567	RASA1
Vitamin A and carotenoid metabolism	1/39	0.5019970629700183	0.767134368827468	0	0	1.461756373937677	1.0073854989854567	RARG
FAS pathway and stress induction of heat shock protein regulation	1/39	0.5019970629700183	0.767134368827468	0	0	1.461756373937677	1.0073854989854567	PRKDC
Transport of inorganic cations/anions and amino acids/oligopeptides	2/95	0.5033900919356509	0.767134368827468	0	0	1.1945869990224829	0.8199524254317969	SLC12A6;SLC12A7
G-protein signaling pathways	2/95	0.5033900919356509	0.767134368827468	0	0	1.1945869990224829	0.8199524254317969	PRKCQ;PRKACB
Transcriptional activity of SMAD2/SMAD3-SMAD4 heterotrimer	1/41	0.5195045746658427	0.78959183364331	0	0	1.388526912181303	0.9093180357326811	MEN1
Senescence and autophagy	2/99	0.5254200804988979	0.7920887953043134	0	0	1.1450913776944704	0.7369317813195746	IL6ST;IGF1R
Granule cell survival pathway	2/99	0.5254200804988979	0.7920887953043134	0	0	1.1450913776944704	0.7369317813195746	PRKACB;PLCB2
Signaling events mediated by T cell protein tyrosine phosphatase (TC-PTP)	1/42	0.5280267930758455	0.7920887953043134	0	0	1.3545913079527396	0.8650531874835885	INSR
Netrin-1 signaling	1/42	0.5280267930758455	0.7920887953043134	0	0	1.3545913079527396	0.8650531874835885	PRKCQ
Neuroactive ligand-receptor interaction	5/272	0.5286792909861224	0.7920887953043134	0	0	1.039835592329073	0.6627634285858951	GABRR2;TBXA2R;GRM6;S1PR1;GPR83
Pyrimidine metabolism	2/100	0.5308239047065556	0.7920887953043134	0	0	1.1333487940630798	0.7177780596011828	ENTPD5;CTPS2
Integrin-mediated cell adhesion	2/100	0.5308239047065556	0.7920887953043134	0	0	1.1333487940630798	0.7177780596011828	CAPN3;ITGA6
Pancreatic secretion	2/101	0.5361857622164884	0.7921551884708977	0	0	1.1218434343434343	0.6992165252676384	ATP1B3;PLCB2
Cleavage of growing transcript in the termination region	1/43	0.5363982777080424	0.7921551884708977	0	0	1.3222716848779172	0.8236143900098101	PAPOLA
Growth hormone receptor signaling	1/43	0.5363982777080424	0.7921551884708977	0	0	1.3222716848779172	0.8236143900098101	INSR
Insulin secretion regulation by glucagon-like peptide-1	1/43	0.5363982777080424	0.7921551884708977	0	0	1.3222716848779172	0.8236143900098101	PRKACB
NCAM1 interactions	1/44	0.5446216871339778	0.801764277960075	0	0	1.2914553000856446	0.7847707351410479	CACNB1
Chagas disease	2/104	0.5520175273610644	0.801764277960075	0	0	1.088680926916221	0.6468675131266641	MAPK11;PLCB2
RhoA signaling pathway	1/45	0.5526996331487428	0.801764277960075	0	0	1.2620396600566572	0.7483145329226042	SCAI
Signaling by FGFR mutants	1/45	0.5526996331487428	0.801764277960075	0	0	1.2620396600566572	0.7483145329226042	ZMYM2
Defensins	1/45	0.5526996331487428	0.801764277960075	0	0	1.2620396600566572	0.7483145329226042	TLR1
G alpha (z) signaling events	1/45	0.5526996331487428	0.801764277960075	0	0	1.2620396600566572	0.7483145329226042	PRKCQ
Interleukin-3, interleukin-5, and GM-CSF signaling	1/45	0.5526996331487428	0.801764277960075	0	0	1.2620396600566572	0.7483145329226042	PRKACB
Amoebiasis	2/105	0.5572096110007528	0.806265421978362	0	0	1.0780560458958517	0.6304620403943101	PRKACB;PLCB2
Alpha-6 beta-1 and alpha-6 beta-4 integrin signaling	1/46	0.5606346818698816	0.8071449063101562	0	0	1.233931381806736	0.7140585398768503	ITGA6
RhoA activity regulation	1/46	0.5606346818698816	0.8071449063101562	0	0	1.233931381806736	0.7140585398768503	ARHGEF18
Actions of nitric oxide in the heart	1/47	0.5684293539223444	0.8097023188010548	0	0	1.207045202611159	0.6818335708829382	PRKACB
Delta Np63 pathway	1/47	0.5684293539223444	0.8097023188010548	0	0	1.207045202611159	0.6818335708829382	ATM
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	1/47	0.5684293539223444	0.8097023188010548	0	0	1.207045202611159	0.6818335708829382	MAPK11
Actin cytoskeleton regulation	4/226	0.5694145645543126	0.8097023188010548	0	0	0.99994851994852	0.5631175348785006	PIKFYVE;ARPC5L;ITGA6;FGF13
Activation of chaperones by IRE1 alpha	1/48	0.5760861258212626	0.8097023188010548	0	0	1.1813031161473089	0.6514864305393904	ADD1
Post-translational regulation of adherens junction stability and disassembly	1/48	0.5760861258212626	0.8097023188010548	0	0	1.1813031161473089	0.6514864305393904	IGF1R
Presenilin action in Notch and Wnt signaling	1/48	0.5760861258212626	0.8097023188010548	0	0	1.1813031161473089	0.6514864305393904	LRP6
Energy metabolism	1/48	0.5760861258212626	0.8097023188010548	0	0	1.1813031161473089	0.6514864305393904	PRKAG2
N-glycan biosynthesis	1/48	0.5760861258212626	0.8097023188010548	0	0	1.1813031161473089	0.6514864305393904	ST6GAL1
Signaling by interleukins	2/109	0.5775486612039887	0.8097023188010548	0	0	1.0375424808836025	0.569571995412979	IL6ST;PRKACB
Leptin influence on immune response	2/110	0.5825256575435673	0.8097023188010548	0	0	1.0278829966329965	0.5554495180306094	SELL;IL16
Angiopoietin receptor Tie2-mediated signaling	1/49	0.5836074304796434	0.8097023188010548	0	0	1.1566336166194524	0.622878119678283	RASA1
Arf6 integrin-mediated signaling pathway	1/49	0.5836074304796434	0.8097023188010548	0	0	1.1566336166194524	0.622878119678283	ITGA6
FoxO family signaling	1/49	0.5836074304796434	0.8097023188010548	0	0	1.1566336166194524	0.622878119678283	KAT2B
G alpha 12 pathway	1/49	0.5836074304796434	0.8097023188010548	0	0	1.1566336166194524	0.622878119678283	MAPK11
Signaling by EGFR in cancer	2/111	0.5874594266597483	0.8130779021160284	0	0	1.0184007506255213	0.5417363406200462	EPS15L1;PRKACB
Aquaporin-mediated transport	1/50	0.5909956578792304	0.8140396922230746	0	0	1.1329710354396716	0.5958822738188654	PRKACB
Type 2 diabetes mellitus	1/50	0.5909956578792304	0.8140396922230746	0	0	1.1329710354396716	0.5958822738188654	INSR
Nuclear receptor transcription pathway	1/51	0.5982531561669036	0.8187090197703165	0	0	1.1102549575070821	0.570383799156817	RARG
Immune system	17/998	0.6000426070476905	0.8187090197703165	0	0	0.9597939485234288	0.4902191882169206	ERAP1;HUWE1;ASB13;UBE4A;UBE3A;UBR1;RASGRP2;TLR1;MAPK11;CDC23;SELL;IGHD;BTLA;PRKCQ;EVL;IL6ST;PRKACB
Pyruvate metabolism	1/52	0.6053822319165765	0.8187090197703165	0	0	1.0884297061600845	0.5462776800561289	ACSS1
Signaling events mediated by PTP1B	1/52	0.6053822319165765	0.8187090197703165	0	0	1.0884297061600845	0.5462776800561289	INSR
Vitamin B12 metabolism	1/52	0.6053822319165765	0.8187090197703165	0	0	1.0884297061600845	0.5462776800561289	INSR
Fas signaling pathway	2/115	0.6067617845862338	0.8187090197703165	0	0	0.9821500402252614	0.49070083282132093	MAPK11;PRKDC
CXCR4 signaling pathway	2/116	0.6114792058666069	0.8187090197703165	0	0	0.9734848484848485	0.47883220718258424	ITGA6;PLCB2
Protein folding	1/53	0.6123851514247564	0.8187090197703165	0	0	1.067443887557202	0.5234679305120253	XRN2
Amyotrophic lateral sclerosis (ALS)	1/53	0.6123851514247564	0.8187090197703165	0	0	1.067443887557202	0.5234679305120253	MAPK11
Androgen receptor regulation of biosynthesis and transcription	1/53	0.6123851514247564	0.8187090197703165	0	0	1.067443887557202	0.5234679305120253	KAT2B
Thrombin signaling through protease-activated receptors	1/53	0.6123851514247564	0.8187090197703165	0	0	1.067443887557202	0.5234679305120253	CYTH3
GABA A and B receptor activation	1/53	0.6123851514247564	0.8187090197703165	0	0	1.067443887557202	0.5234679305120253	GABRR2
Calcium signaling pathway	3/178	0.6129601561631166	0.8187090197703165	0	0	0.950964590964591	0.46545470029960834	TBXA2R;PRKACB;PLCB2
Leukocyte transendothelial migration	2/117	0.6161534109362953	0.8210602429453423	0	0	0.9649703557312252	0.4672958716187311	MAPK11;RHOH
Phospholipase C-mediated cascade	1/54	0.6192641408334016	0.8232908415256129	0	0	1.0472499866374472	0.5018666735406504	PRKACB
RNA polymerase I transcription	1/55	0.6260213872041283	0.8246212755585414	0	0	1.0278040079739796	0.48139332749273106	KAT2B
Calcineurin-dependent NFAT signaling role in lymphocytes	1/55	0.6260213872041283	0.8246212755585414	0	0	1.0278040079739796	0.48139332749273106	PRKCQ
Vibrio cholerae infection	1/55	0.6260213872041283	0.8246212755585414	0	0	1.0278040079739796	0.48139332749273106	PRKACB
Meiotic synapsis	1/55	0.6260213872041283	0.8246212755585414	0	0	1.0278040079739796	0.48139332749273106	DIDO1
Signaling by PDGF	2/122	0.6388782619266794	0.8342817445615347	0	0	0.9245265151515152	0.4142261136648715	RASA1;PRKACB
TGF-beta signaling pathway	3/185	0.6389285214139642	0.8342817445615347	0	0	0.9140602986756833	0.40946491107019234	MAPK11;STAMBPL1;LEF1
Pathogenic Escherichia coli infection	1/57	0.639179207438942	0.8342817445615347	0	0	0.9909955483609875	0.44354028794831324	ARPC5L
Keratinocyte differentiation	1/57	0.639179207438942	0.8342817445615347	0	0	0.9909955483609875	0.44354028794831324	PRKCQ
Autodegradation of Cdh1 by Cdh1-APC/C	1/58	0.6455839656819015	0.8379238311439304	0	0	0.9735599622285175	0.426029838146369	CDC23
Tryptophan metabolism	1/58	0.6455839656819015	0.8379238311439304	0	0	0.9735599622285175	0.426029838146369	UBE3A
p75 neurotrophin receptor-mediated signaling	2/124	0.647668222217846	0.8379238311439304	0	0	0.9092771982116244	0.39496884374590774	ARHGEF18;PRKACB
ATF2 transcription factor network	1/59	0.6518753510785644	0.8379238311439304	0	0	0.9567256032040637	0.40938471741520144	MAPK11
Factors involved in megakaryocyte development and platelet production	2/125	0.6519993492860089	0.8379238311439304	0	0	0.9018385070214339	0.38572689456654896	DOCK11;PRKACB
Chemokine signaling pathway	3/189	0.653210910475157	0.8379238311439304	0	0	0.8942192813160555	0.38080794422120195	RASGRP2;PRKACB;PLCB2
RAGE pathway	1/60	0.6580553647727202	0.8379238311439304	0	0	0.940461900417727	0.3935515273095268	ID3
Selenium pathway	1/60	0.6580553647727202	0.8379238311439304	0	0	0.940461900417727	0.3935515273095268	INSR
Ephrin receptor B forward pathway	1/60	0.6580553647727202	0.8379238311439304	0	0	0.940461900417727	0.3935515273095268	RASA1
Natural killer cell receptor signaling pathway	1/60	0.6580553647727202	0.8379238311439304	0	0	0.940461900417727	0.3935515273095268	MAPK11
Neurotrophic factor-mediated Trk receptor signaling	1/60	0.6580553647727202	0.8379238311439304	0	0	0.940461900417727	0.3935515273095268	RASA1
Glucose metabolism	1/61	0.6641259729095286	0.8408286890804021	0	0	0.9247403210576015	0.3784808897799364	PRKACB
Licensing factor removal from origins	1/61	0.6641259729095286	0.8408286890804021	0	0	0.9247403210576015	0.3784808897799364	ORC5
Signaling by FGFR in disease	2/128	0.6647389112625168	0.8408286890804021	0	0	0.8802308802308803	0.35945190092074747	ZMYM2;PRKACB
PDGFB signaling pathway	2/129	0.6689013176701218	0.8442300771475326	0	0	0.8732551896921976	0.3511522739173053	RASA1;S1PR1
Folate metabolism	1/63	0.675946664034498	0.8465547838068187	0	0	0.8948186055012337	0.35044774779917054	INSR
O-linked glycosylation of mucins	1/63	0.675946664034498	0.8465547838068187	0	0	0.8948186055012337	0.35044774779917054	ST6GAL1
Ubiquitin-mediated degradation of phosphorylated Cdc25A	1/64	0.6817005085240153	0.8465547838068187	0	0	0.8805701695220108	0.33740354101328107	ATM
Validated nuclear estrogen receptor alpha network	1/64	0.6817005085240153	0.8465547838068187	0	0	0.8805701695220108	0.33740354101328107	TRIM59
MAPK cascade role in angiogenesis	1/64	0.6817005085240153	0.8465547838068187	0	0	0.8805701695220108	0.33740354101328107	MAPK11
Axon guidance	5/325	0.6847904854342944	0.8465547838068187	0	0	0.8652399713467048	0.3276164944939717	EPHB6;CACNB1;RASA1;PRKCQ;EVL
Adipogenesis	2/133	0.685134773164401	0.8465547838068187	0	0	0.8464174184594032	0.32006403794013416	ID3;IL6ST
Cell adhesion molecules (CAMs)	2/133	0.685134773164401	0.8465547838068187	0	0	0.8464174184594032	0.32006403794013416	SELL;ITGA6
Tight junction	2/133	0.685134773164401	0.8465547838068187	0	0	0.8464174184594032	0.32006403794013416	PRKCQ;ASH1L
FSH regulation of apoptosis	4/263	0.6873003559344304	0.8465547838068187	0	0	0.8554660783232212	0.32078599180838335	GPRC5B;RASSF2;SLC12A6;FGF13
Glioma	1/65	0.6873524714019408	0.8465547838068187	0	0	0.8667669971671388	0.32495793296410774	IGF1R
Retinoblastoma protein regulation	1/66	0.6929043518418813	0.8465547838068187	0	0	0.8533885378078012	0.3130769434812749	MAPK11
Beta-1 integrin cell surface interactions	1/66	0.6929043518418813	0.8465547838068187	0	0	0.8533885378078012	0.3130769434812749	ITGA6
Thyroid-stimulating hormone signaling pathway	1/66	0.6929043518418813	0.8465547838068187	0	0	0.8533885378078012	0.3130769434812749	IGF1R
Endochondral ossification	1/66	0.6929043518418813	0.8465547838068187	0	0	0.8533885378078012	0.3130769434812749	IGF1R
NGF signaling via TRKA from the plasma membrane	2/136	0.6968780461460055	0.849598128599279	0	0	0.8273405698778833	0.2987897886483242	MAPK11;PRKACB
CD8/T cell receptor downstream pathway	1/68	0.7037149028885423	0.8507393301590038	0	0	0.8278296900765295	0.2908844292552701	PRKCQ
Epithelial cell signaling in Helicobacter pylori infection	1/68	0.7037149028885423	0.8507393301590038	0	0	0.8278296900765295	0.2908844292552701	MAPK11
Messenger RNA splicing: major pathway	1/68	0.7037149028885423	0.8507393301590038	0	0	0.8278296900765295	0.2908844292552701	PAPOLA
Capped intron-containing pre-mRNA processing	2/138	0.7045042647816415	0.8507393301590038	0	0	0.8150902406417112	0.2854942364045022	METTL3;PAPOLA
p53 signaling pathway	2/139	0.7082572268743903	0.8507393301590038	0	0	0.8090992037159921	0.2790971007269501	PPP1R13B;MSH2
Phase I of biological oxidations: functionalization of compounds	1/69	0.7089770153681024	0.8507393301590038	0	0	0.8156140643226129	0.2805159161311073	ACSS1
NFAT involvement in hypertrophy of the heart	1/69	0.7089770153681024	0.8507393301590038	0	0	0.8156140643226129	0.2805159161311073	PRKACB
Signaling events mediated by VEGFR1 and VEGFR2	1/70	0.7141459298542423	0.8507393301590038	0	0	0.8037525146775054	0.27059771462007587	MAPK11
MicroRNA regulation of DNA damage response	1/70	0.7141459298542423	0.8507393301590038	0	0	0.8037525146775054	0.27059771462007587	ATM
NCAM signaling for neurite out-growth	1/70	0.7141459298542423	0.8507393301590038	0	0	0.8037525146775054	0.27059771462007587	CACNB1
Nucleotide metabolism	1/70	0.7141459298542423	0.8507393301590038	0	0	0.8037525146775054	0.27059771462007587	CTPS2
RIG-I-like receptor signaling pathway	1/71	0.7192232924784993	0.8515421966700296	0	0	0.7922298664508296	0.26110582065057586	MAPK11
Rac1 cell motility signaling pathway	1/71	0.7192232924784993	0.8515421966700296	0	0	0.7922298664508296	0.26110582065057586	PLCB2
Toll-like receptor signaling pathway regulation	2/142	0.7192782254595015	0.8515421966700296	0	0	0.7916396103896104	0.2608508203452043	TLR1;MAPK11
Costimulation by the CD28 family	1/72	0.7242107202212578	0.8521000876525271	0	0	0.7810317998643419	0.2520177793855341	BTLA
Leishmaniasis	1/72	0.7242107202212578	0.8521000876525271	0	0	0.7810317998643419	0.2520177793855341	MAPK11
Myocyte adrenergic pathway	1/72	0.7242107202212578	0.8521000876525271	0	0	0.7810317998643419	0.2520177793855341	PRKACB
Degradation of beta-catenin by the destruction complex	1/73	0.729109801619503	0.8543556571124237	0	0	0.7701447906830343	0.2433125667400963	AMER1
Myc repressed pathway	1/73	0.729109801619503	0.8543556571124237	0	0	0.7701447906830343	0.2433125667400963	ITGA6
Seven transmembrane receptor signaling through beta-arrestin	1/74	0.733922097305285	0.8564915718043347	0	0	0.7595560557258721	0.2349704815284941	MAPK11
Integrins in angiogenesis	1/74	0.733922097305285	0.8564915718043347	0	0	0.7595560557258721	0.2349704815284941	IGF1R
VEGF signaling pathway	1/76	0.7432924370364842	0.8656637528900516	0	0	0.7392256846081209	0.2193029215555822	MAPK11
Mitochondrial pathway of apoptosis: caspases	1/77	0.7478534667058829	0.8669915831974416	0	0	0.7294617563739377	0.21194381510917382	CAPN3
Peroxisome	1/78	0.7523336828575283	0.8669915831974416	0	0	0.7199514366653177	0.20488041497026627	HSD17B4
Apoptosis regulation	1/78	0.7523336828575283	0.8669915831974416	0	0	0.7199514366653177	0.20488041497026627	ATM
Signaling by NGF	3/221	0.7528961403012621	0.8669915831974416	0	0	0.7617031286756057	0.2161926669085673	MAPK11;ARHGEF18;PRKACB
EGFR1 pathway	2/152	0.753511009480499	0.8669915831974416	0	0	0.7384848484848485	0.2089998153960204	TCOF1;ID3
Integrated breast cancer pathway	2/152	0.753511009480499	0.8669915831974416	0	0	0.7384848484848485	0.2089998153960204	MSH2;ATM
Unfolded protein response	1/79	0.7567345135705554	0.8672177525518564	0	0	0.7106849713082007	0.19809831575217196	ADD1
Fc epsilon receptor I signaling pathway	1/79	0.7567345135705554	0.8672177525518564	0	0	0.7106849713082007	0.19809831575217196	MAPK11
MAP kinase signaling pathway	1/81	0.7653036043193231	0.8746635128398202	0	0	0.6928470254957507	0.1853245622319414	MAPK11
APC/C-mediated degradation of cell cycle proteins	1/82	0.7694745962282797	0.8746635128398202	0	0	0.6842583849193858	0.1793080893648735	CDC23
SMAD2/3 nuclear pathway	1/82	0.7694745962282797	0.8746635128398202	0	0	0.6842583849193858	0.1793080893648735	KAT2B
Response to elevated platelet cytosolic calcium	1/83	0.7735716667933432	0.8746635128398202	0	0	0.675879223381469	0.17352317757854915	ABCC4
Toll receptor cascades	2/159	0.775284298432366	0.8746635128398202	0	0	0.7053054429646787	0.1795182065653068	TLR1;MAPK11
Small cell lung cancer	1/84	0.7775961226553695	0.8746635128398202	0	0	0.6677019693504898	0.16795910309571552	ITGA6
Cell junction organization	1/84	0.7775961226553695	0.8746635128398202	0	0	0.6677019693504898	0.16795910309571552	ITGA6
ECM-receptor interaction	1/84	0.7775961226553695	0.8746635128398202	0	0	0.6677019693504898	0.16795910309571552	ITGA6
C-Myb transcription factor network	1/85	0.7815492470750226	0.8746635128398202	0	0	0.6597194118440577	0.1626057373508191	LEF1
TGF-beta regulation of skeletal system development	1/85	0.7815492470750226	0.8746635128398202	0	0	0.6597194118440577	0.1626057373508191	ID3
Myc active pathway	1/85	0.7815492470750226	0.8746635128398202	0	0	0.6597194118440577	0.1626057373508191	HUWE1
NOD signaling pathway	1/85	0.7815492470750226	0.8746635128398202	0	0	0.6597194118440577	0.1626057373508191	MAPK11
mRNA stability regulation by proteins that bind AU-rich elements	1/86	0.785432300947529	0.877295727958936	0	0	0.65192467922013	0.15745350757960483	MAPK11
DNA replication pre-Initiation	1/88	0.792993129364689	0.8805912076084628	0	0	0.6368727817394418	0.1477167324939134	ORC5
HIF-1 degradation in normoxia	1/88	0.792993129364689	0.8805912076084628	0	0	0.6368727817394418	0.1477167324939134	MAPK11
Hematopoietic cell lineage	1/88	0.792993129364689	0.8805912076084628	0	0	0.6368727817394418	0.1477167324939134	ITGA6
Oncostatin M	4/311	0.8035610635433597	0.8891888171213576	0	0	0.7199255467659377	0.15744922874110046	EPHB6;ZBTB18;RARG;IL6ST
Neural crest differentiation	1/91	0.8038391051812622	0.8891888171213576	0	0	0.6155492603084671	0.1344089652394377	HDAC10
Cell cycle	6/453	0.8159879352252377	0.9007383058280102	0	0	0.740530741340739	0.1505911542308353	ORC5;DIDO1;CDC23;PRKDC;ATM;MEN1
RNA polymerase I, RNA polymerase III, and mitochondrial transcription	1/95	0.8174239424617195	0.9007383058280102	0	0	0.5892351274787535	0.11878827987212949	KAT2B
Potassium channels	1/99	0.8300704447202815	0.9129181666501369	0	0	0.565069087124935	0.10524112749082251	KCNN4
Transcription	2/181	0.8331219975144717	0.9142435866923442	0	0	0.6179215337734891	0.11281714263209844	KAT2B;PAPOLA
RNA polymerase II transcription	1/101	0.8360621979525102	0.9142435866923442	0	0	0.5537110481586403	0.09914321965403305	PAPOLA
TNF-alpha signaling pathway	1/101	0.8360621979525102	0.9142435866923442	0	0	0.5537110481586403	0.09914321965403305	RFFL
Signaling by ERBB2	1/102	0.8389785951557179	0.915685209569955	0	0	0.548200712422517	0.0962476457700979	PRKACB
Chromosome maintenance	1/103	0.8418432538282331	0.9170649894364593	0	0	0.5427984224851413	0.09344895881473231	DIDO1
Interleukin-4 signaling pathway	1/104	0.8446570893686144	0.9183842736398787	0	0	0.5375010313815012	0.09074336726790817	MAPK11
Glycosaminoglycan metabolism	1/110	0.8605220759485812	0.9336220400757052	0	0	0.5077578813317046	0.07627336240468957	ABCC5
Post-translational protein modification	2/196	0.8644894835515825	0.9336220400757052	0	0	0.5697047797563262	0.08295821023176772	ST6GAL1;ST8SIA6
S phase	1/112	0.8654427798899447	0.9336220400757052	0	0	0.49855804813311894	0.07204862711711177	ORC5
Lipid and lipoprotein metabolism	6/489	0.8671638041502283	0.9336220400757052	0	0	0.6840508317269937	0.09749597825362803	INPP4B;PIKFYVE;PRKAG2;HSD17B4;LDLRAP1;PRKACB
mTOR signaling pathway	1/113	0.8678378236086712	0.9336220400757052	0	0	0.49408134358559286	0.07003623843132212	CAB39L
Signal transduction	14/1020	0.8689362787861152	0.9336220400757052	0	0	0.7629517015553736	0.10718363865258186	AMER1;HDAC10;CAB39L;INSR;DGKA;ARHGEF18;EPS15L1;GMIP;DGKZ;KAT2B;MAPK11;GRM6;ITGA6;MEN1
G alpha (i) signaling events	2/199	0.8700770844684581	0.9336220400757052	0	0	0.5609425473004154	0.0780683198928213	RGS14;S1PR1
TGF-beta regulation of extracellular matrix	7/565	0.8757000628433407	0.9378993196434284	0	0	0.6900726142150331	0.09159447028028234	DPP4;INPP4B;INSR;STK38;S1PR1;VRK3;SSBP2
Phospholipid metabolism	2/205	0.8806228679483196	0.9396449553015778	0	0	0.5441950291088222	0.06918123789972278	INPP4B;PIKFYVE
Immunoregulatory interactions between a lymphoid and a non-lymphoid cell	1/119	0.8813411939592934	0.9396449553015778	0	0	0.46881451961396264	0.05921617186192097	SELL
Interleukin-1 regulation of extracellular matrix	1/120	0.8834539937014776	0.9396449553015778	0	0	0.4648510962458638	0.057602516963466355	PRKDC
Lysosome	1/121	0.8855292772475601	0.9396449553015778	0	0	0.4609537299338999	0.0560380340194529	GGA3
Notch signaling pathway	1/121	0.8855292772475601	0.9396449553015778	0	0	0.4609537299338999	0.0560380340194529	KAT2B
Influenza viral RNA transcription and replication	1/125	0.8934683616529819	0.9445707956220639	0	0	0.445992872155716	0.05023857917927494	SMG1
Interleukin-1 signaling pathway	1/125	0.8934683616529819	0.9445707956220639	0	0	0.445992872155716	0.05023857917927494	MAPK11
Neurotrophin signaling pathway	1/126	0.8953657974917406	0.9448335211100689	0	0	0.44240226628895185	0.04889559556101539	MAPK11
Mitotic G1-G1/S phases	1/135	0.9109955874129578	0.9595596904184279	0	0	0.41249841444336394	0.03845195767958502	ORC5
Diabetes pathways	1/137	0.9141395010677439	0.9611044662602152	0	0	0.4063906015664056	0.03648253454714911	ADD1
Biological oxidations	1/139	0.9171726614912311	0.9625273535429953	0	0	0.4004598267438519	0.034623570377782	ACSS1
Focal adhesion	2/233	0.9201491755632426	0.9638856994474188	0	0	0.47754329004329005	0.03974090175927075	ITGA6;IGF1R
Carbohydrate metabolism	2/235	0.9224419986986003	0.964524206668427	0	0	0.47339543503706594	0.0382175822851468	ABCC5;PRKACB
Signaling by the B cell receptor (BCR)	1/151	0.9332544194461966	0.9740524268536807	0	0	0.36819641170915957	0.025434060256246005	IGHD
Phagosome	1/154	0.9367623256810758	0.975738044335071	0	0	0.360921327926827	0.023577432427676855	PIKFYVE
SLC-mediated transmembrane transport	2/251	0.9386760984827414	0.975738044335071	0	0	0.44261135450894484	0.028010572076139616	SLC12A6;SLC12A7
Class A GPCRs (rhodopsin-like)	2/253	0.9404629536028317	0.975738044335071	0	0	0.4390392973560304	0.0269495584645275	TBXA2R;GPR83
Developmental biology	4/420	0.94168087001273	0.975738044335071	0	0	0.5282967032967033	0.03174473659681796	CACNB1;MAPK11;PRKCQ;EVL
BDNF signaling pathway	2/261	0.9471285196299352	0.9778997774162032	0	0	0.4253027378027378	0.023102649976089348	GPRC5B;ADD3
Purine metabolism	1/164	0.9471804126806157	0.9778997774162032	0	0	0.3386051200055614	0.018374641912455626	ENTPD5
Cytokine-cytokine receptor interaction	2/265	0.9501891183728551	0.9790673040738275	0	0	0.4187478396128586	0.021395603549764945	IL6ST;RELT
Alzheimer's disease	1/169	0.951728600993232	0.9790673040738275	0	0	0.328443275327128	0.01624985185644254	PLCB2
Fatty acid, triacylglycerol, and ketone body metabolism	1/173	0.9550842393947013	0.9798260495165845	0	0	0.32073917912905986	0.01473980427155799	PRKAG2
Metapathway biotransformation	1/174	0.9558861460379944	0.9798260495165845	0	0	0.3188688205145	0.014386234658095088	CHST10
Gene expression	11/968	0.9589189988284503	0.9799030834636863	0	0	0.6262859823732448	0.026271865171299834	RARS2;TNRC6C;KAT2B;MAPK11;RARG;SMG1;MARS2;METTL3;PAPOLA;TARS2;MEN1
Immune system signaling by interferons, interleukins, prolactin, and growth hormones	2/280	0.9602291668942992	0.9799030834636863	0	0	0.3958469587965991	0.016064778849159765	IL6ST;PRKACB
Signaling by GPCR	11/977	0.9620759978971178	0.9799030834636863	0	0	0.6201522312563003	0.02397622109628318	RGS14;TBXA2R;GRM6;DGKA;S1PR1;ARHGEF18;PRKCQ;RASGRP2;PRKACB;PLCB2;DGKZ
Huntington's disease	1/184	0.9631603083349777	0.9799030834636863	0	0	0.30128949364541247	0.011309025697251108	PLCB2
Generic transcription pathway	3/377	0.9645119355558797	0.9799030834636863	0	0	0.44042232277526394	0.015913811432912133	KAT2B;RARG;MEN1
Peptide G-protein coupled receptors	1/192	0.9681080717764698	0.9818157966865793	0	0	0.28855138454236684	0.009352398649180006	ATP8A1
Jak-STAT signaling pathway	1/199	0.9718904023592726	0.9839102483248467	0	0	0.2782499213094114	0.007933527326915707	IL6ST
DNA replication	1/207	0.9756682684173553	0.9849430308373786	0	0	0.2673340850958497	0.006585144080340452	ORC5
GPCR ligand binding	3/410	0.9774371416208106	0.9849430308373786	0	0	0.404019404019404	0.009220245777606178	TBXA2R;GRM6;S1PR1
Innate immune system	2/319	0.9780673377774318	0.9849430308373786	0	0	0.346447519357614	0.007683083068242431	TLR1;MAPK11
Protein metabolism	3/442	0.9856038037040984	0.9907911921446463	0	0	0.3739462258824446	0.005422529503632048	ST6GAL1;XRN2;ST8SIA6
Disease	4/674	0.9979808298395105	0.9995872821758014	0	0	0.3236844349680171	6.542346805783589E-4	ZMYM2;EPS15L1;PRKACB;ADD1
Metabolism	14/1615	0.9994173958084772	0.9995872821758014	0	0	0.4641033177793291	2.7046733359154825E-4	ST6GAL1;ADPGK;DGKA;ABCC5;HSD17B4;CTPS2;ADO;DGKZ;DPP4;INPP4B;PIKFYVE;LDLRAP1;ACSS1;PLCB2
Olfactory transduction	1/432	0.9995872821758014	0.9995872821758014	0	0	0.12629565606041684	5.2135227684052494E-5	PRKACB
